BTIG Maintains Buy on Boston Scientific, Raises Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Marie Thibault maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $80 to $84.
July 15, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Marie Thibault maintains a Buy rating on Boston Scientific and raises the price target from $80 to $84.
The Buy rating and increased price target from a reputable analyst can boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100